AbbVie (ABBV) Share-based Compensation (2012 - 2026)
AbbVie (ABBV) recorded Share-based Compensation of $166 million in Q2 2026, down 7.3% from $179 million a year earlier and down 62.6% from the prior quarter.
Powered by 
Analysis
AbbVie (ABBV) Share-based Compensation (2012 - 2026) Analysis & Trends
On a TTM basis, AbbVie's Share-based Compensation came in at $976 million as of Jun 30, 2026, up 4.5% year-over-year; for FY2025, it was $955 million, up 4.8% from FY2024.
- Annual Share-based Compensation has increased for three straight years, with a five-year compound annual growth rate of 4.9% (FY2020 to FY2025).
- Across earlier years, Share-based Compensation came in at $911 million in FY2024 (+22.0%), $747 million in FY2023 (+11.3%), $671 million in FY2022 (-3.0%) and $692 million in FY2021 (-8.1%).
- Quarterly Share-based Compensation has ranged from $107 million in Q2 2022 to $444 million in Q1 2026 over the past five years.
- On a year-over-year basis, Share-based Compensation rose in five of the last eight quarters, with growth averaging 10.3%.
- Peak year-over-year performance for Share-based Compensation in the last five years was growth of 67.3% in Q2 2023, against a decline of 32.7% in Q2 2022 at the low end.
- Per Business Quant, the preceding three quarters came in at $444 million (Q1 2026), $157 million (Q4 2025) and $209 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 201.00 Mn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 458.00 Mn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 166.00 Mn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 298.00 Mn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | - |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 165.00 Mn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 231.00 Mn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 249.00 Mn |
| 10 | Vertex Pharmaceuticals | 127.87 Bn | 99.88 Bn | 2.84 Bn | 170.20 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 166.00 Mn |
| Mar 31, 2026 | 444.00 Mn |
| Dec 31, 2025 | 157.00 Mn |
| Sep 30, 2025 | 209.00 Mn |
| Jun 30, 2025 | 179.00 Mn |
| Mar 31, 2025 | 410.00 Mn |
| Dec 31, 2024 | 164.00 Mn |
| Sep 30, 2024 | 181.00 Mn |
| Jun 30, 2024 | 218.00 Mn |
| Mar 31, 2024 | 348.00 Mn |
| Dec 31, 2023 | 125.00 Mn |
| Sep 30, 2023 | 130.00 Mn |
| Jun 30, 2023 | 179.00 Mn |
| Mar 31, 2023 | 313.00 Mn |
| Dec 31, 2022 | 132.00 Mn |
| Sep 30, 2022 | 126.00 Mn |
| Jun 30, 2022 | 107.00 Mn |
| Mar 31, 2022 | 306.00 Mn |
| Dec 31, 2021 | 129.00 Mn |
| Sep 30, 2021 | 135.00 Mn |
API Access
AbbVie Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=ABBV&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "ABBV", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=ABBV&period=max&api_key=YOUR_API_KEY");
const data = await res.json();